A patient with a long history of inflammation in his right hand seemed an unlikely candidate for the infection that was finally diagnosed.Read More
Dr. Carol Langford, a Cleveland Clinic rheumatologist and an expert in vasculitic diseases, reflects on a year of advances in rheumatology.
Watch as Juliette Yedimenko, MD, discusses a rare case of sarcoidosis involving the gastrointestinal tract.
As work continues toward expanding the knowledge of and therapies for EDS, this coordinated care program provides a central resource and care team for patients whose multisystem symptoms warrant multidisciplinary care.
A patient presents with persistent swelling of the fingers and hands and limited range of motion. Puffy hand syndrome, a common complication of IV drug use, is not a well-recognized condition among general practitioners.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The future of healthcare since 1921, Cleveland Clinic has made a significant impact on the field of rheumatology. In this article, Abby Abelson, MD, reviews contributions to research, education and patient care.
Patient reported outcomes measures (PROMS) are very important in rheumatology, as clinical tests may not be indicative of a patient’s quality of life. A new study examines the patient experience of these measures.
Researchers have discovered a novel disorder that connects seemingly unrelated adult-onset inflammatory syndromes. In this article,Rheumatologist Carol Langford, MD, MHS, presents a case of VEXAS syndrome.
New data question the efficacy of IL-6 inhibitors for the treatment of COVID-19. This article explores what we know about the safety and efficacy of targeting IL-6.
Flu season is here, and the stakes are especially high for patients with autoimmune diseases. Rheumatologists Cassandra Calabrese, DO, and Leonard Calabrese, DO, address common patient concerns about the influenza vaccine and share best practices for maximizing vaccination coverage.
A third phase of COVID-19 infection is marked by a severe respiratory illness, often accompanied by multisystem dysfunction, coagulopathy and shock. In this article, Leonard Calabrese, DO, discusses the three stages of the disease and potential treatments.